[Antifungal treatment options in the critically ill patient]

Rafael Zaragoza1, Javier Pemán

  • 1Servicio de Medicina Intensiva, Hospital Universitario Dr. Peset, Valencia, España.

Insights

New antifungal therapies offer improved outcomes for invasive fungal infections in critically ill patients. Early echinocandin use for candidiasis and voriconazole for aspergillosis are recommended.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Mycology

Context:

  • Invasive fungal infections (IFIs) pose significant challenges in critical care settings.
  • High morbidity, mortality, incidence, and healthcare costs necessitate effective interventions.
  • Limited data exist on antifungal drug efficacy specifically in critically ill populations.

Purpose:

  • To review the role of new antifungal drugs in treating invasive mycosis in critically ill patients.
  • To evaluate therapeutic strategies for early intervention against IFIs.
  • To provide evidence-based recommendations for antifungal use in intensive care units.

Summary:

  • New antifungal agents are being analyzed for various clinical situations in critical care.
  • Evidence suggests early echinocandin therapy is a viable option for invasive candidiasis, especially with non-Candida albicans species.
  • Voriconazole is recommended as a first-line treatment for invasive aspergillosis.

Impact:

  • Optimizing antifungal strategies can reduce mortality associated with IFIs in critical care.
  • Early and targeted antifungal therapy can improve patient outcomes and lower healthcare costs.
  • This review supports evidence-based decision-making for managing IFIs in complex, critically ill patients.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...